{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:16:13Z","timestamp":1792271773152,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Vagus nerve stimulation (VNS) has been used as an adjunctive therapy for patients with drug-resistant epilepsy (DRE) for decades. Nonetheless, the predictors of response to VNS remain inadequately characterized. We aimed to find factors associated with responder status.\u00a0We retrospectively reviewed records of patients who received VNS for DRE in our medical center between 2000 and 2023. Preoperative data and VNS parameters were analyzed with univariate and multivariate analysis to identify predictors associated with responder status. We used receiver operating characteristic (ROC) curves to select possible related factors and the cutoff values.\u00a0The overall responder rate was 35.8%. Individuals with generalized epilepsy demonstrated significantly higher responder rates (86%) compared to those with focal (29%) or combined epilepsy (28%). Univariate analysis indicated that an epilepsy duration of &lt;\u20095 years at the time of VNS implantation (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.021) and a diagnosis of generalized epilepsy (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.016) were associated with a favorable response. A multivariate logistic regression analysis confirmed these findings. There was no correlation between age at implantation, prior epilepsy surgery, VNS parameters, such as output current and duty cycle, and the responder status.\u00a0An epilepsy duration of &lt;\u20095 years at VNS implantation and generalized epilepsy are independent predictors of responder status to VNS. Future long-term, randomized controlled trials with larger cohorts are needed to better evaluate these critical variables and their association with VNS outcomes.\n                  <\/jats:p>","DOI":"10.1007\/s10143-025-03839-w","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T03:49:36Z","timestamp":1759463376000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Outcome and predictors of response to vagus nerve stimulation for drug-resistant epilepsy: a retrospective cohort study"],"prefix":"10.1007","volume":"48","author":[{"given":"Robert","family":"Crutcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Horvat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yitao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"5","key":"3839_CR1","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/j.1528-1167.2009.02481.x","volume":"51","author":"AK Ngugi","year":"2010","unstructured":"Ngugi AK, Bottomley C, Kleinschmidt I, Sander JW, Newton CR (2010) Estimation of the burden of active and life-time epilepsy: a meta-analytic approach. Epilepsia 51(5):883\u201390. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02481.x","journal-title":"Epilepsia"},{"issue":"6","key":"3839_CR2","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia 51(6):1069\u201377. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02397.x","journal-title":"Epilepsia"},{"key":"3839_CR3","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.seizure.2020.09.027","volume":"83","author":"DH Toffa","year":"2020","unstructured":"Toffa DH, Touma L, El Meskine T, Bouthillier A, Nguyen DK (2020) Learnings from 30 years of reported efficacy and safety of vagus nerve stimulation (VNS) for epilepsy treatment: a critical review. Seizure 83:104\u2013123. https:\/\/doi.org\/10.1016\/j.seizure.2020.09.027","journal-title":"Seizure"},{"issue":"6","key":"3839_CR4","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1001\/archpedi.157.6.560","volume":"157","author":"JV Murphy","year":"2003","unstructured":"Murphy JV, Torkelson R, Dowler I, Simon S, Hudson S (2003) Vagal nerve stimulation in refractory epilepsy: the first 100 patients receiving vagal nerve stimulation at a pediatric epilepsy center. Arch Pediatr Adolesc Med 157(6):560\u2013564. https:\/\/doi.org\/10.1001\/archpedi.157.6.560","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"Suppl 3","key":"3839_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1528-1167.2010.02620.x","volume":"51","author":"K Muller","year":"2010","unstructured":"Muller K et al (2010) Outcome of vagus nerve stimulation for epilepsy in Budapest. Epilepsia 51(Suppl 3):98\u2013101. https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02620.x","journal-title":"Epilepsia"},{"issue":"3","key":"3839_CR6","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/00127893-200305000-00004","volume":"9","author":"SL Helmers","year":"2003","unstructured":"Helmers SL et al (2003) Observations on the use of vagus nerve stimulation earlier in the course of pharmacoresistant epilepsy: patients with seizures for six years or less. Neurologist 9(3):160\u20134. https:\/\/doi.org\/10.1097\/00127893-200305000-00004","journal-title":"Neurologist"},{"issue":"1","key":"3839_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yebeh.2010.10.017","volume":"20","author":"RE Elliott","year":"2011","unstructured":"Elliott RE et al (2011) Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response. Epilepsy Behav 20(1):57\u201363. https:\/\/doi.org\/10.1016\/j.yebeh.2010.10.017","journal-title":"Epilepsy Behav"},{"issue":"6","key":"3839_CR8","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.3171\/2011.7.JNS11977","volume":"115","author":"DJ Englot","year":"2011","unstructured":"Englot DJ, Chang EF, Auguste KI (2011) Vagus nerve stimulation for epilepsy: a meta-analysis of efficacy and predictors of response. J Neurosurg 115(6):1248\u20131255. https:\/\/doi.org\/10.3171\/2011.7.JNS11977","journal-title":"J Neurosurg"},{"key":"3839_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.yebeh.2016.10.005","volume":"66","author":"DJ Englot","year":"2017","unstructured":"Englot DJ, Hassnain KH, Rolston JD, Harward SC, Sinha SR, Haglund MM (2017) Quality-of-life metrics with vagus nerve stimulation for epilepsy from provider survey data. Epilepsy Behav 66:4\u20139. https:\/\/doi.org\/10.1016\/j.yebeh.2016.10.005","journal-title":"Epilepsy Behav"},{"issue":"2\u20133","key":"3839_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0920-1211(00)00181-9","volume":"42","author":"G Elger","year":"2000","unstructured":"Elger G, Hoppe C, Falkai P, Rush AJ, Elger CE (2000) Vagus nerve stimulation is associated with mood improvements in epilepsy patients. Epilepsy Res 42(2\u20133):203\u201310. https:\/\/doi.org\/10.1016\/s0920-1211(00)00181-9","journal-title":"Epilepsy Res"},{"issue":"2","key":"3839_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/ebeh.2000.0046","volume":"1","author":"CL Harden","year":"2000","unstructured":"Harden CL, Pulver MC, Ravdin LD, Nikolov B, Halper JP, Labar DR (2000) A pilot study of mood in epilepsy patients treated with vagus nerve stimulation. Epilepsy Behav 1(2):93\u201399. https:\/\/doi.org\/10.1006\/ebeh.2000.0046","journal-title":"Epilepsy Behav"},{"issue":"5","key":"3839_CR12","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/00004691-200109000-00002","volume":"18","author":"K Vonck","year":"2001","unstructured":"Vonck K, Van Laere K, Dedeurwaerdere S, Caemaert J, De Reuck J, Boon P (2001) The mechanism of action of vagus nerve stimulation for refractory epilepsy: the current status. J Clin Neurophysiol 18(5):394\u2013401. https:\/\/doi.org\/10.1097\/00004691-200109000-00002","journal-title":"J Clin Neurophysiol"},{"key":"3839_CR13","doi-asserted-by":"crossref","unstructured":"Henry TR et al (1998) Brain blood flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: I. Acute effects at high and low levels of stimulation, Epilepsia, vol. 39, no. 9, pp. 983\u2013990","DOI":"10.1111\/j.1528-1157.1998.tb01448.x"},{"issue":"5","key":"3839_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3171\/2023.1.PEDS22312","volume":"31","author":"N Muthiah","year":"2023","unstructured":"Muthiah N et al (2023) Development of a clinical model to predict vagus nerve stimulation response in pediatric patients with drug-resistant epilepsy. J Neurosurg Pediatr 31(5):476\u2013483. https:\/\/doi.org\/10.3171\/2023.1.PEDS22312","journal-title":"J Neurosurg Pediatr"},{"issue":"4","key":"3839_CR15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.nec.2011.07.002","volume":"22","author":"DJ Englot","year":"2011","unstructured":"Englot DJ, Chang EF, Auguste KI (2011) Efficacy of vagus nerve stimulation for epilepsy by patient age, epilepsy duration, and seizure type. Neurosurg Clin N Am 22(4):443\u2013448. https:\/\/doi.org\/10.1016\/j.nec.2011.07.002","journal-title":"Neurosurg Clin N Am"},{"key":"3839_CR16","doi-asserted-by":"publisher","unstructured":"Zhu J et al (Nov 2020) Epilepsy duration as an independent predictor of response to vagus nerve stimulation. Epilepsy Res 167:106432. https:\/\/doi.org\/10.1016\/j.eplepsyres.2020.106432","DOI":"10.1016\/j.eplepsyres.2020.106432"},{"key":"3839_CR17","doi-asserted-by":"publisher","unstructured":"Lagae L et al (2015) Vagus nerve stimulation in children with drug-resistant epilepsy: age at implantation and shorter duration of epilepsy as predictors of better efficacy? Epileptic Disord, vol. 17, no. 3, pp. 308\u2009\u2013\u200914, Sep https:\/\/doi.org\/10.1684\/epd.2015.0768","DOI":"10.1684\/epd.2015.0768"},{"key":"3839_CR18","doi-asserted-by":"publisher","first-page":"1296161","DOI":"10.3389\/fnins.2024.1296161","volume":"18","author":"A Berger","year":"2024","unstructured":"Berger A et al (2024) Locus coeruleus features are linked to vagus nerve stimulation response in drug-resistant epilepsy. Front Neurosci 18:1296161. https:\/\/doi.org\/10.3389\/fnins.2024.1296161","journal-title":"Front Neurosci"},{"issue":"5","key":"3839_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurot.2024.e00422","volume":"21","author":"A Berger","year":"2024","unstructured":"Berger A (2024) Identifying responders to vagus nerve stimulation based on microstructural features of thalamocortical tracts in drug-resistant epilepsy. Neurotherapeutics 21(5):e00422. https:\/\/doi.org\/10.1016\/j.neurot.2024.e00422","journal-title":"Neurotherapeutics"},{"issue":"Suppl 2","key":"3839_CR20","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1111\/j.1528-1157.1990.tb05847.x","volume":"31","author":"SA Reid","year":"1990","unstructured":"Reid SA (1990) Surgical technique for implantation of the neurocybernetic prosthesis. Epilepsia 31(Suppl 2):S38\u2013S39. https:\/\/doi.org\/10.1111\/j.1528-1157.1990.tb05847.x","journal-title":"Epilepsia"},{"issue":"1","key":"3839_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1214\/aos\/1033066197","volume":"24","author":"F Hsieh","year":"1996","unstructured":"Hsieh F, Turnbull BW (1996) Nonparametric and semiparametric estimation of the receiver operating characteristic curve. Ann Stat 24(1):25\u201340","journal-title":"Ann Stat"},{"key":"3839_CR22","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-\u00c1lvarez MX, In\u00e1cio V (2021) ROCnReg: an R package for receiver operating characteristic curve inference with and without covariates","DOI":"10.32614\/CRAN.package.ROCnReg"},{"key":"3839_CR23","first-page":"33","volume":"1","author":"G Heinze","year":"2013","unstructured":"Heinze G, Ploner M, Dunkler D, Southworth H (2013) Firth\u2019s bias reduced logistic regression. R Package Version 1:33","journal-title":"R Package Version"},{"issue":"8","key":"3839_CR24","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1046\/j.1528-1157.2001.0420081017.x","volume":"42","author":"CM DeGiorgio","year":"2001","unstructured":"DeGiorgio CM (2001) Vagus nerve stimulation: analysis of device parameters in 154 patients during the long-term XE5 study. Epilepsia 42(8):1017\u20131020","journal-title":"Epilepsia"},{"issue":"5","key":"3839_CR25","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.seizure.2010.03.002","volume":"19","author":"K Ghaemi","year":"2010","unstructured":"Ghaemi K et al (2010) Vagus nerve stimulation: outcome and predictors of seizure freedom in long-term follow-up. Seizure 19(5):264\u20138. https:\/\/doi.org\/10.1016\/j.seizure.2010.03.002","journal-title":"Seizure"},{"issue":"6","key":"3839_CR26","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00381-009-1069-2","volume":"26","author":"G Colicchio","year":"2010","unstructured":"Colicchio G et al (2010) Vagal nerve stimulation for drug-resistant epilepsies in different age, aetiology and duration. Childs Nerv Syst 26(6):811\u2013819. https:\/\/doi.org\/10.1007\/s00381-009-1069-2","journal-title":"Childs Nerv Syst"},{"issue":"6 Suppl 4","key":"3839_CR27","doi-asserted-by":"publisher","first-page":"S26","DOI":"10.1212\/wnl.59.6_suppl_4.s26","volume":"59","author":"JB Renfroe","year":"2002","unstructured":"Renfroe JB, Wheless JW (2002) Earlier use of adjunctive vagus nerve stimulation therapy for refractory epilepsy. Neurology 59(6 Suppl 4):S26-30. https:\/\/doi.org\/10.1212\/wnl.59.6_suppl_4.s26","journal-title":"Neurology"},{"issue":"7","key":"3839_CR28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.seizure.2006.06.001","volume":"15","author":"F Rychlicki","year":"2006","unstructured":"Rychlicki F, Zamponi N, Trignani R, Ricciuti RA, Iacoangeli M, Scerrati M (2006) Vagus nerve stimulation: clinical experience in drug-resistant pediatric epileptic patients. Seizure 15(7):483\u201390. https:\/\/doi.org\/10.1016\/j.seizure.2006.06.001","journal-title":"Seizure"},{"key":"3839_CR29","doi-asserted-by":"publisher","unstructured":"Kavcic A, Kajdic N, Rener-Primec Z, Krajnc N, Zgur T (Jun 2019) Efficacy and tolerability of vagus nerve stimulation therapy (VNS) in Slovenian epilepsy patients: younger age and shorter duration of epilepsy might result in better outcome. Acta Clin Croat 58(2):255\u2013264. https:\/\/doi.org\/10.20471\/acc.2019.58.02.08","DOI":"10.20471\/acc.2019.58.02.08"},{"key":"3839_CR30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.yebeh.2018.09.014","volume":"88","author":"J Soleman","year":"2018","unstructured":"Soleman J et al (2018) Improved quality of life and cognition after early vagal nerve stimulator implantation in children. Epilepsy Behav 88:139\u2013145. https:\/\/doi.org\/10.1016\/j.yebeh.2018.09.014","journal-title":"Epilepsy Behav"},{"issue":"6","key":"3839_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.seizure.2003.09.009","volume":"13","author":"D Labar","year":"2004","unstructured":"Labar D (2004) Vagus nerve stimulation for 1 year in 269 patients on unchanged antiepileptic drugs. Seizure 13(6):392\u20138. https:\/\/doi.org\/10.1016\/j.seizure.2003.09.009","journal-title":"Seizure"},{"key":"3839_CR32","doi-asserted-by":"publisher","unstructured":"Chrastina J, Kocvarova J, Novak Z, Dolezalova I, Svoboda M, Brazdil M (Mar 2018) Older age and longer epilepsy duration do not predict worse seizure reduction outcome after vagus nerve stimulation. J Neurol Surg Cent Eur Neurosurg 79(2):152\u2013158. https:\/\/doi.org\/10.1055\/s-0037-1607396","DOI":"10.1055\/s-0037-1607396"},{"key":"3839_CR33","doi-asserted-by":"publisher","unstructured":"Bernasconi A, Bernasconi N, Natsume J, Antel SB, Andermann F, Arnold DL (2003) Magnetic resonance spectroscopy and imaging of the thalamus in idiopathic generalized epilepsy, Brain, vol. 126, no. Pt 11, pp. 2447-54, Nov https:\/\/doi.org\/10.1093\/brain\/awg249","DOI":"10.1093\/brain\/awg249"},{"key":"3839_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.seizure.2025.02.014","volume":"127","author":"F Jaafar","year":"2025","unstructured":"Jaafar F et al (2025) Impact of vagus nerve stimulation on refractory epilepsy with myoclonic atonic seizures: case series insights. Seizure 127:25\u201328. https:\/\/doi.org\/10.1016\/j.seizure.2025.02.014","journal-title":"Seizure"},{"issue":"3","key":"3839_CR35","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1059-1311(03)00147-X","volume":"13","author":"M Ng","year":"2004","unstructured":"Ng M, Devinsky O (2004) Vagus nerve stimulation for refractory idiopathic generalised epilepsy. Seizure 13(3):176\u20138. https:\/\/doi.org\/10.1016\/S1059-1311(03)00147-X","journal-title":"Seizure"},{"issue":"3","key":"3839_CR36","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ejpn.2016.01.011","volume":"20","author":"E Bodin","year":"2016","unstructured":"Bodin E, Le Moing AG, Bourel-Ponchel E, Querne L, Toussaint P, Berquin P (2016) Vagus nerve stimulation in the treatment of drug-resistant epilepsy in 29 children. Eur J Paediatr Neurol 20(3):346\u2013351. https:\/\/doi.org\/10.1016\/j.ejpn.2016.01.011","journal-title":"Eur J Paediatr Neurol"},{"issue":"2","key":"3839_CR37","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/epi.17152","volume":"63","author":"KH Kostov","year":"2022","unstructured":"Kostov KH et al (2022) Norwegian population-based study of long-term effects, safety, and predictors of response of vagus nerve stimulation treatment in drug-resistant epilepsy: the NORpulse study. Epilepsia 63(2):414\u2013425. https:\/\/doi.org\/10.1111\/epi.17152","journal-title":"Epilepsia"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03839-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-025-03839-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-025-03839-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:15:18Z","timestamp":1772079318000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-025-03839-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3839"],"URL":"https:\/\/doi.org\/10.1007\/s10143-025-03839-w","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of WRNMMC and was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The requirement for informed consent was waived due to the retrospective nature of the study, as deemed by the institutional review board statement.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The views expressed in this article are those of the authors and do not reflect the official policy of the Department of Health Agency, Uniformed Services University of Health Sciences, or the U.S. government.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}},{"value":"not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"676"}}